Abstract:Objective To investigate germline mutation of breast cancer susceptibility genes BRCA1/2,TP53 and PTEN in Chinese breast cancer patients. Methods All of128 female breast cancer patients in Peking University People′s Hospital from January 2016 to August 2018 were selected as objects. Among them,44 cases were sporadic breast cancer and 84 werebreast cancer patients with genetic high risks. Germline mutations of BRCA1,BRCA2,TP53 and PTENwere detected by NGS.χ2 test was used to analyze the difference of pathogenic mutation rates between sporadic breast cancer group and breast cancer with high genetic risks.Groups were divided according to the clinical features of the patients(family history, triple-negative breast cancer,age and bilateral breast cancer).Among them,there were 42 cases with family history of breast cancer,34 cases of triple-negative breast cancer,33 cases of early-onset breast cancer and 7 cases of bilateral breast cancer. Fisher′s exact probability test compared the relationship between pathogenic mutations of BRCA1/2 gene and clinical characteristics of breast cancer patients with hereditary risk factors. Results In 128 cases of breast cancer,30 germline mutations of BRCA1/2 were detected, including 13 pathogenic mutations and 3 newly discovered mutations(BRCA1:c. 4760C>G,BRCA2:c. 44134414del and BRCA2:c. 64826485del). The new mutations may be unique mutations of Chinese population. There were 3 cases of TP53 mutations,including 1 pathogenic mutation. All of the 3 mutations were found in early-onset breast cancer. Germline mutation of T53 has important detection significance for early-onset hereditary breast cancer. There were 5 cases of PTEN mutations,including 3 pathogenic mutations. Among 84 breast cancer patients with genetic high risks,the carry mutation rate was 40.5％(34/84)and the pathogenic mutation rate was 15.4(13/84). Among 44 sporadic cases,the carry mutation rate was 9％(4/44). The pathogenic mutation rate was 6.8％(3/44). Breast cancer susceptibility genes were carried at a higher rate in breast cancer patients with genetic high risks(P<0.001). BRCA1/2 mutations did not show statistical differences among groups of breast cancer patients with hereditary high risk factors . Conclusion Germline mutation detection of breast cancer susceptibility genes by next-generation sequencing is of great significance in breast cancer risk prediction and prognosis evaluation.

Pancreatic neuroendocrine tumor susceptibility gene site, and detection method and kit thereof

The Emerging Genetic Basis and Its Clinical Implication in Pancreatic Cancer

Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1

Mutation and Expression of Gene YY1 in Pancreatic Neuroendocrine Tumors and Its Clinical Significance

Single-Cell Sequencing Identifies Cellular Origins and Differentiation Markers for Molecular Classification and Recurrence Prediction of PitnNET

Primary Application of Genechip for Detecting Interleukin-1B Susceptibility Gene of Gastric Cancer

A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets

Identification Of Genetic Variants Predictive Of Early Onset Pancreatic Cancer Through A Population Science Analysis Of Functional Genomic Datasets

A Functional Single Nucleotide Polymorphism Site Detected in Nasopharyngeal Carcinoma-Associated Transforming Gene Tx

Identification and analysis of tumor-related gene mutations in 8 human pancreatic cancer cell lines by next-generation sequencing

ESR1 gene polymorphism related to liver cancer and detecting method thereof

High Throughput Gene Sequencing Reveals Altered Landscape in DNA Damage Responses and Chromatin Remodeling in Sporadic Pancreatic Neuroendocrine Tumors.

Three New Pancreatic Cancer Susceptibility Signals Identified on Chromosomes 1q32.1, 5p15.33 and 8Q24.21.

Whole-genome Sequencing Reveals Distinct Genetic Bases for Insulinomas and Non-Functional Pancreatic Neuroendocrine Tumours: Leading to a New Classification System

Application of next-generation sequencing in detection of breast cancer susceptibility genes BRCA1/2,TP53 and PTEN germline mutation

Identification and Characterization of Germline Pathogenic Variants Using Matched Tumor-Normal Next-Generation Sequencing in 7363 Pan-Cancer Patients in China

Risk SNP in a Transcript of RP11-638I2.4 Increases Lncrna–yy1 Interaction and Pancreatic Cancer Susceptibility

Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic Cancer

Application of MLH1 gene, and kit for detecting gastrointestinal stromal tumor

YTHDC1 gene polymorphisms and neuroblastoma susceptibility in Chinese children

Identification of Novel SNPs by Next-Generation Sequencing of the Genomic Region Containing Theapcgene in Colorectal Cancer Patients in China